Blog

Section 14 hearing in patent prosecution

Pre-Grant Opposition Hearing Cannot Substitute Section 14 Hearing: Delhi High Court Reaffirms Distinct Statutory Safeguards

In a significant ruling on patent prosecution procedure, the Delhi High Court in Fresenius Kabi Ipsum S.R.L. v. The Assistant Controller of Patents and Designs & Anr.[1], [i]has once again reaffirmed that a hearing granted to an applicant during pre-grant opposition proceedings under Section 25(1) of the Patents Act, 1970 cannot substitute the applicant’s independent […]
Read more
Indian FSSAI New Labelling Rules 2026

Indian FSSAI’s New Labelling Rules 2026

Background The Food Safety and Standard (Labelling and Display) First Amendment Regulation, 2026 were notified by FSSAI on March 24, 2026 to amend the existing Food Safety And Standards (Labelling And Display) 2020. The Amendment aims to simplify certain labelling requirements while improving clarity and traceability. It introduces relaxations for infant nutrition products and small packages, clarifies […]
Read more
GenAI patent trends

Beyond the Model: What GenAI Patent Trends Reveal About the Future of AI Innovation

Generative Artificial Intelligence (“GenAI”) is moving beyond chatbots and large language models (“LLMs”) into multimodal systems, reasoning models, agentic AI, semiconductor infrastructure, data centres, energy systems and sector-specific applications. WIPO’s recent analysis, “Beyond the Chatbot: What Patent Data Reveals About the Next Phase of GenAI,” captures this shift through global patent activity. [1]  The numbers are striking: published GenAI patent families increased […]
Read more
Well-Known Trademarks under Section 11(2)

Well-Known Trademarks Without a Formal Declaration: Delhi High Court Clarifies the Scope of Section 11(2)

The Delhi High Court’s decision in Columbia Pictures Industries, Inc. v. Registrar of Trade Marks & Anr., C.A. (COMM. IPD-TM) 44/2025, decided on 6 July 2026, addresses an important question concerning the protection of well-known trademarks in India: whether a trademark must first be formally declared “well known” under Rule 124 of the Trade Marks […]
Read more
Beyond the Source Code

Beyond the Source Code: Can India’s Patent Framework Accommodate Black-box Software?

Introduction The rapid growth of Artificial Intelligence (AI), machine learning, and data-driven technologies has increased the significance of “black box” software systems. A black box algorithm is generally understood as a computational model where the inputs and outputs are known, but the internal decision-making process is either opaque or not readily understandable. While such technologies have […]
Read more

Array Biopharma v. Controller of Patents: Delhi HC on Combination Drug Patents

The Delhi High Court’s decision in Array Biopharma Inc. v. Deputy Controller of Patents and Designs [C.A.(COMM.IPD-PAT) 37/2023] provides significant guidance on inventive step, the exclusions under Sections 3(d) and Section 3(i) of the Patent Act, and the standard of reasoning expected from the Patent Office when refusing combination patents involving multiple independently known active […]
Read more
Explore Intra-Cellular Therapies v. Controller of Patents on Section 3(d), deuterated compounds, novelty, inventive step and therapeutic efficacy in India.Section 3(d) of Patents Act, deuterated compounds Section 3(d) , Delhi High Court Section 3(d) 2026 , Intra-Cellular Therapies patent case

Deuterated Compounds and Section 3(d): Delhi High Court’s Decision in Intra-Cellular Therapies v. Controller of Patents

The Delhi High Court’s decision in Intra-Cellular Therapies, Inc. v. The Controller of Patents [C.A.(COMM.IPD-PAT) 24/2023], provides significant guidance on novelty, inventive step and the enhanced efficacy requirement under Section 3(d) of the Patents Act, 1970. The judgment is particularly relevant to pharmaceutical inventions involving modifications of known compounds and the evidentiary burden required to […]
Read more
FSSAI’s warning to food influencers highlights misleading claims, advertising compliance and the legal responsibility of promoting food products.misleading food advertisements in India, FSSAI rules for influencers, food advertising laws in India

When Promotion Becomes Liability: FSSAI’s Warning to Food Influencers in India

Influencer advertising is now a central part of India’s advertising ecosystem. As influencers increasingly become the face of commercial campaigns, questions of advertising compliance have followed. Recent data from the Advertising Standards Council of India (ASCI) illustrates the scale of the concern: of the 37,532 advertising violation cases processed by ASCI, 21.12% involved influencer violations. […]
Read more
Explore the Dabur-FSSAI case, 100% claims, food advertising rules and what the Delhi High Court's interim order means for brands and advertisers in India.FSSAI Advertising Guidelines, Misleading Claims in Advertising, Advertising Laws in India

100% Pure” or Procedurally Impure? The Dabur-FSSAI Dispute

“100% Pure” sounds reassuring. For a consumer, it may suggest that a product is natural, completely pure and free from anything that might compromise its quality. But in advertising law, absolute claims invite close scrutiny: can the advertiser substantiate the claim, and is the overall consumer impression accurate? These questions came before the Delhi High […]
Read more
Learn how Crocs lost its registered design and paid $25,000 in litigation costs, highlighting key lessons under design law in India.design protection in India, design law in India

The Battle of the Clogs: How Crocs Lost its Design and Paid $25,000 – A Lesson in Indian Design Law

For over two decades, Crocs’ iconic perforated clogs have been recognised worldwide for their distinctive appearance. Their unique shape became synonymous with the brand, making them an obvious subject for IP protection. Recently, in Crocs Inc. USA v. Bata India Ltd. [CS(COMM) 625/2018] the Delhi High Court directed Crocs to pay USD 25,812 (₹24.63 lakh) […]
Read more

Subscribe To Our Newsletter

Reach us at knk@kankrishme.com

knk@kankrishme.com
X